Susanne J. Goldie, M.D.

Concepts (515)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Uterine Cervical Neoplasms	55	2012	1975	5.540	Why?
Papillomavirus Vaccines	27	2012	486	4.910	Why?
Papillomavirus Infections	37	2011	1516	4.160	Why?
Cost-Benefit Analysis	101	2012	5268	2.790	Why?
Human papillomavirus 16	15	2011	269	2.680	Why?
Human papillomavirus 18	14	2011	128	2.630	Why?
Mass Screening	42	2011	5214	2.400	Why?
Cervical Intraepithelial Neoplasia	11	2010	307	1.880	Why?
Papillomaviridae	15	2006	1144	1.620	Why?
Vaccination	15	2013	2963	1.620	Why?
Quality-Adjusted Life Years	37	2010	1616	1.490	Why?
Markov Chains	21	2010	985	1.460	Why?
Tumor Virus Infections	7	2004	457	1.200	Why?
Alphapapillomavirus	5	2011	227	1.180	Why?
AIDS-Related Opportunistic Infections	15	2007	656	1.140	Why?
Health Care Costs	21	2012	3179	1.060	Why?
Helicobacter Infections	4	2013	335	1.040	Why?
Developing Countries	9	2013	2732	1.000	Why?
Helicobacter pylori	4	2013	331	0.990	Why?
Vaginal Smears	11	2011	502	0.990	Why?
Maternal Mortality	3	2012	290	0.960	Why?
Models, Theoretical	22	2013	3567	0.950	Why?
Rotavirus Vaccines	4	2011	72	0.950	Why?
Rotavirus Infections	4	2011	95	0.930	Why?
Stomach Neoplasms	5	2013	1262	0.860	Why?
DNA, Viral	14	2011	2293	0.850	Why?
Immunization Programs	7	2010	276	0.770	Why?
Models, Economic	10	2010	723	0.770	Why?
Models, Econometric	10	2010	220	0.690	Why?
Anus Neoplasms	5	2008	295	0.630	Why?
Colposcopy	8	2008	143	0.600	Why?
Early Detection of Cancer	6	2012	2943	0.580	Why?
Health Policy	10	2008	2625	0.570	Why?
Decision Support Techniques	9	2011	2043	0.570	Why?
HIV Infections	32	2011	15673	0.560	Why?
Abortion, Induced	2	2010	375	0.550	Why?
Sexually Transmitted Diseases, Viral	2	2004	37	0.520	Why?
Computer Simulation	19	2013	6100	0.510	Why?
Cost of Illness	7	2008	1843	0.510	Why?
Life Expectancy	19	2011	1124	0.510	Why?
Chlamydia trachomatis	2	2006	244	0.500	Why?
Chlamydia Infections	2	2006	351	0.440	Why?
Hepatitis C, Chronic	3	2007	1002	0.440	Why?
Herpes Genitalis	2	2003	133	0.440	Why?
Female	109	2012	377934	0.430	Why?
Precancerous Conditions	3	2010	944	0.410	Why?
Adult	77	2013	212470	0.410	Why?
Anti-HIV Agents	14	2011	4056	0.390	Why?
Humans	158	2013	717280	0.380	Why?
Empirical Research	1	2010	116	0.380	Why?
Hepatitis C	3	2004	1518	0.370	Why?
Office Visits	2	2006	633	0.360	Why?
CD4 Lymphocyte Count	19	2010	2526	0.360	Why?
Maternal Health Services	3	2012	435	0.360	Why?
Anti-Infective Agents	3	2006	938	0.360	Why?
Syphilis, Congenital	1	2008	24	0.360	Why?
Guideline Adherence	2	2011	2334	0.360	Why?
Cholera Vaccines	1	2011	250	0.350	Why?
Antiretroviral Therapy, Highly Active	10	2010	1876	0.350	Why?
Program Evaluation	4	2012	2535	0.340	Why?
Diagnostic Techniques and Procedures	2	2008	202	0.340	Why?
Disease Outbreaks	2	2011	1728	0.330	Why?
Viral Vaccines	2	2004	635	0.330	Why?
Diagnostic Tests, Routine	3	2004	791	0.330	Why?
Models, Statistical	6	2008	5032	0.310	Why?
Sensitivity and Specificity	22	2010	14904	0.310	Why?
Pelvic Inflammatory Disease	2	2006	96	0.310	Why?
United States	44	2013	67804	0.310	Why?
Hepatitis B Vaccines	1	2007	192	0.300	Why?
Antiviral Agents	6	2007	2797	0.300	Why?
Pneumococcal Vaccines	1	2010	428	0.300	Why?
Health Services Administration	1	2006	63	0.290	Why?
Developed Countries	1	2008	403	0.290	Why?
Adolescent	28	2012	85143	0.280	Why?
Ribavirin	2	2007	394	0.280	Why?
Interferon-alpha	3	2007	898	0.280	Why?
Pneumococcal Infections	1	2010	549	0.270	Why?
Uterine Cervical Dysplasia	2	2004	114	0.270	Why?
Epidemiologic Research Design	1	2008	363	0.270	Why?
Cholera	1	2011	759	0.270	Why?
Models, Biological	11	2010	9892	0.270	Why?
Herpesvirus 2, Human	2	2003	180	0.260	Why?
Calibration	4	2009	799	0.260	Why?
Adenocarcinoma	3	2013	6370	0.260	Why?
Monte Carlo Method	5	2009	1306	0.250	Why?
Delivery of Health Care, Integrated	1	2012	964	0.250	Why?
Family Planning Services	3	2012	238	0.240	Why?
Health Resources	2	2006	924	0.240	Why?
Middle Aged	44	2013	215054	0.240	Why?
Genital Neoplasms, Female	1	2008	510	0.240	Why?
Pneumonia, Pneumocystis	2	2002	245	0.230	Why?
Drug Costs	8	2010	1158	0.230	Why?
DNA Probes, HPV	3	2008	20	0.230	Why?
Pentamidine	1	2002	43	0.230	Why?
Hepatitis B	1	2007	645	0.230	Why?
Anti-Retroviral Agents	3	2008	1602	0.230	Why?
Dapsone	1	2002	64	0.220	Why?
Therapeutics	1	2002	119	0.220	Why?
Naphthoquinones	1	2002	84	0.220	Why?
Antiprotozoal Agents	1	2002	91	0.220	Why?
Practice Guidelines as Topic	4	2011	7486	0.220	Why?
Oncogene Proteins, Viral	1	2003	387	0.220	Why?
Gonorrhea	1	2005	308	0.210	Why?
Carcinoma, Squamous Cell	6	2006	4038	0.210	Why?
HIV Seropositivity	2	2006	897	0.210	Why?
Disease Progression	14	2010	13308	0.210	Why?
Prenatal Diagnosis	1	2008	1172	0.210	Why?
Pregnancy Outcome	3	2011	2703	0.210	Why?
HIV	4	2010	1517	0.210	Why?
Time Management	1	2001	59	0.210	Why?
Bisexuality	2	2000	282	0.210	Why?
Pregnancy	14	2012	27304	0.200	Why?
Mass Media	1	2004	313	0.200	Why?
Health Education	3	2004	1061	0.200	Why?
Women's Health Services	1	2001	93	0.200	Why?
Endoscopy	1	2010	1758	0.190	Why?
Dilatation and Curettage	2	2010	54	0.190	Why?
China	4	2010	2282	0.190	Why?
Vacuum Curettage	2	2010	48	0.190	Why?
Point-of-Care Systems	1	2008	1125	0.190	Why?
Pregnancy Complications, Infectious	4	2011	2034	0.190	Why?
Asia	3	2011	640	0.190	Why?
Health Status Disparities	1	2011	1728	0.190	Why?
Sexually Transmitted Diseases	2	2005	566	0.190	Why?
Gambia	2	2010	101	0.190	Why?
Abortifacient Agents, Nonsteroidal	2	2010	62	0.180	Why?
Primary Prevention	2	2008	1152	0.180	Why?
Child	19	2012	74388	0.180	Why?
HIV Seronegativity	1	2000	207	0.180	Why?
Brazil	3	2007	1158	0.180	Why?
Misoprostol	2	2010	84	0.180	Why?
Choice Behavior	2	2002	797	0.180	Why?
Risk Factors	21	2013	70863	0.180	Why?
Molecular Diagnostic Techniques	1	2004	628	0.180	Why?
Drug Resistance, Viral	4	2007	773	0.180	Why?
Nigeria	2	2012	705	0.170	Why?
Smoking	2	2013	8948	0.170	Why?
Cesarean Section	2	2004	1321	0.170	Why?
Mexico	3	2010	679	0.170	Why?
Pharyngeal Neoplasms	2	2008	120	0.170	Why?
RNA, Viral	8	2006	2837	0.170	Why?
Forecasting	3	2009	2948	0.160	Why?
Direct Service Costs	4	2006	64	0.160	Why?
Neoplasms	5	2011	20572	0.160	Why?
Polyethylene Glycols	1	2003	1181	0.160	Why?
Stochastic Processes	2	2008	332	0.160	Why?
Incidence	11	2013	20654	0.160	Why?
South Africa	4	2009	1571	0.160	Why?
Mass Vaccination	2	2008	108	0.160	Why?
Decision Trees	3	2009	524	0.150	Why?
Delivery of Health Care	5	2013	4874	0.150	Why?
Patient Compliance	2	2006	2754	0.150	Why?
Cytodiagnosis	2	2004	420	0.150	Why?
Streptococcal Infections	1	2001	645	0.150	Why?
Physical Examination	1	2002	1243	0.150	Why?
Genetic Diseases, Inborn	1	2001	596	0.150	Why?
Healthcare Disparities	1	2011	3031	0.140	Why?
West Nile Fever	2	2006	90	0.140	Why?
Pregnancy Trimester, First	2	2010	842	0.140	Why?
Age Factors	9	2009	18798	0.140	Why?
Male	42	2013	351399	0.140	Why?
Health Services Research	3	2011	1837	0.140	Why?
Overweight	1	2006	2248	0.130	Why?
Weight Loss	1	2006	2495	0.130	Why?
Caribbean Region	3	2008	172	0.130	Why?
Uncertainty	2	2010	659	0.130	Why?
Vietnam	3	2010	395	0.130	Why?
Patient Education as Topic	1	2004	2345	0.120	Why?
Cholesterol	1	2002	2894	0.120	Why?
Latin America	3	2008	352	0.120	Why?
Time Factors	11	2013	41094	0.120	Why?
Staphylococcal Infections	3	2001	1376	0.120	Why?
Pregnancy Complications	1	2007	2830	0.120	Why?
India	2	2010	2015	0.120	Why?
Cote d'Ivoire	3	2007	52	0.120	Why?
Age Distribution	4	2009	2930	0.120	Why?
Quality of Life	8	2008	11758	0.120	Why?
Family Planning Policy	1	2012	5	0.120	Why?
Risk	4	2009	9773	0.110	Why?
Mouth Neoplasms	2	2008	609	0.110	Why?
Preventive Medicine	2	2007	262	0.110	Why?
Homosexuality, Male	1	2000	1151	0.110	Why?
Afghanistan	1	2012	82	0.110	Why?
Pacific Islands	2	2008	50	0.110	Why?
Africa, Eastern	1	2011	70	0.110	Why?
Young Adult	9	2013	56249	0.110	Why?
Zimbabwe	1	2011	109	0.110	Why?
Infant	7	2011	34574	0.110	Why?
Immunity, Herd	1	2011	44	0.110	Why?
Health Services Accessibility	5	2012	5028	0.100	Why?
Cohort Studies	13	2010	39891	0.100	Why?
Acquired Immunodeficiency Syndrome	4	2010	2142	0.100	Why?
France	4	2005	489	0.100	Why?
Public Health	4	2006	2395	0.100	Why?
Air Bags	3	2001	12	0.100	Why?
Aged	20	2013	162862	0.100	Why?
Costs and Cost Analysis	3	2008	1666	0.100	Why?
International Agencies	1	2011	242	0.100	Why?
Financial Support	1	2011	121	0.100	Why?
Teratogens	1	2011	116	0.100	Why?
Ganciclovir	3	2001	262	0.100	Why?
Arthroplasty, Replacement, Hip	1	2001	1367	0.100	Why?
Insurance Claim Reporting	1	2011	168	0.100	Why?
Recombinant Proteins	3	2007	6860	0.100	Why?
Peru	1	2012	847	0.090	Why?
Marketing of Health Services	1	2011	157	0.090	Why?
Directly Observed Therapy	1	2010	143	0.090	Why?
Patient Satisfaction	1	2002	3402	0.090	Why?
Population Surveillance	3	2010	2633	0.090	Why?
Decision Making, Organizational	2	2008	135	0.090	Why?
Prevalence	5	2008	14899	0.090	Why?
Rotavirus	1	2010	113	0.090	Why?
Ghana	1	2010	276	0.090	Why?
Benzoxazines	1	2011	293	0.090	Why?
Africa	1	2011	658	0.090	Why?
Emergency Service, Hospital	2	2007	7497	0.090	Why?
Intensive Care, Neonatal	1	2010	195	0.090	Why?
Health Expenditures	3	2013	2266	0.090	Why?
Health Services Misuse	1	2011	242	0.090	Why?
Cytomegalovirus Infections	3	2001	762	0.090	Why?
Vaccines, Conjugate	1	2010	329	0.090	Why?
Reagent Strips	1	2008	38	0.090	Why?
Human papillomavirus 11	1	2008	16	0.090	Why?
Human papillomavirus 6	1	2008	14	0.090	Why?
Genetic Testing	1	2001	3340	0.090	Why?
Respiratory Tract Neoplasms	1	2008	58	0.090	Why?
Condylomata Acuminata	1	2008	82	0.090	Why?
Warts	1	2008	70	0.080	Why?
Abnormalities, Drug-Induced	1	2011	324	0.080	Why?
Infectious Disease Transmission, Vertical	3	2010	1318	0.080	Why?
Health Planning Guidelines	1	2008	165	0.080	Why?
Vaccines, Attenuated	1	2009	329	0.080	Why?
Drug Therapy, Combination	6	2006	6542	0.080	Why?
Colombia	1	2008	243	0.080	Why?
Endometrial Neoplasms	2	2007	1343	0.080	Why?
Vaginal Neoplasms	1	2008	108	0.080	Why?
Papilloma	1	2008	155	0.080	Why?
Pregnancy Trimester, Third	1	2010	570	0.080	Why?
Microbial Sensitivity Tests	2	2005	1920	0.080	Why?
Virology	2	2005	74	0.080	Why?
Aged, 80 and over	7	2013	58528	0.080	Why?
Risk Assessment	5	2013	23543	0.080	Why?
Penile Neoplasms	1	2008	159	0.080	Why?
West Nile virus	1	2006	81	0.070	Why?
Nutrition Surveys	1	2013	1572	0.070	Why?
Risk Reduction Behavior	1	2013	1122	0.070	Why?
Communicable Disease Control	1	2013	812	0.070	Why?
Health Status Indicators	2	2002	987	0.070	Why?
Public Policy	1	2010	549	0.070	Why?
Treatment Outcome	11	2010	62344	0.070	Why?
Budgets	2	2005	217	0.070	Why?
Penicillins	1	2008	359	0.070	Why?
False Positive Reactions	1	2008	999	0.070	Why?
Africa South of the Sahara	1	2008	689	0.070	Why?
Decision Making	5	2008	3848	0.070	Why?
Atrioventricular Node	1	2006	176	0.070	Why?
Breast Neoplasms	2	2011	20086	0.070	Why?
Health Care Rationing	3	2007	456	0.070	Why?
Sentinel Surveillance	1	2007	292	0.070	Why?
Adolescent Health Services	1	2007	216	0.070	Why?
Vulvar Neoplasms	1	2008	292	0.070	Why?
Carcinoma	2	2009	2325	0.070	Why?
HIV Fusion Inhibitors	1	2005	83	0.070	Why?
National Health Programs	1	2008	444	0.070	Why?
Immunotherapy, Active	1	2004	61	0.070	Why?
Actuarial Analysis	1	2004	383	0.060	Why?
Hong Kong	1	2004	156	0.060	Why?
Urban Health	1	2007	540	0.060	Why?
Child, Preschool	5	2011	41221	0.060	Why?
Triage	2	2008	928	0.060	Why?
Rape	1	2005	131	0.060	Why?
Heart Block	1	2006	407	0.060	Why?
Cancer Vaccines	1	2011	1004	0.060	Why?
Gynecologic Surgical Procedures	1	2007	334	0.060	Why?
Germany	1	2006	837	0.060	Why?
Referral and Consultation	2	2008	3472	0.060	Why?
Obesity	1	2006	12248	0.060	Why?
Health Status	2	2012	3995	0.060	Why?
Evidence-Based Practice	1	2008	510	0.060	Why?
Anti-Obesity Agents	1	2006	202	0.060	Why?
Patient Selection	2	2009	4321	0.060	Why?
HIV-1	5	2007	6795	0.060	Why?
Infant, Newborn	5	2010	24744	0.060	Why?
Nucleic Acid Amplification Techniques	1	2005	299	0.060	Why?
Italy	1	2005	806	0.060	Why?
Chemoprevention	2	2002	314	0.060	Why?
Epidemiologic Methods	1	2008	1366	0.060	Why?
Acetic Acid	1	2002	60	0.060	Why?
HIV Envelope Protein gp41	1	2005	321	0.060	Why?
Income	2	2002	1805	0.060	Why?
Oropharyngeal Neoplasms	1	2008	463	0.060	Why?
Neisseria gonorrhoeae	1	2005	236	0.060	Why?
Diet, Reducing	1	2006	470	0.060	Why?
Atovaquone	1	2002	60	0.060	Why?
Body Constitution	1	2002	275	0.060	Why?
Resource Allocation	1	2004	343	0.060	Why?
Social Class	1	2011	1978	0.060	Why?
Pregnancy, Ectopic	1	2003	137	0.060	Why?
Medical Assistance	1	2002	99	0.050	Why?
Infant Equipment	1	2001	24	0.050	Why?
Massachusetts	3	2011	8749	0.050	Why?
Disease-Free Survival	2	2003	7056	0.050	Why?
Genotype	3	2007	12923	0.050	Why?
Mortality	1	2013	2796	0.050	Why?
Social Values	1	2002	231	0.050	Why?
Fibrosis	1	2008	1964	0.050	Why?
Cost Allocation	1	2001	51	0.050	Why?
Seroepidemiologic Studies	1	2002	378	0.050	Why?
Cause of Death	3	2010	3592	0.050	Why?
Longitudinal Studies	2	2007	13613	0.050	Why?
Smoking Cessation	1	2013	2045	0.050	Why?
Pelvic Pain	1	2003	248	0.050	Why?
Rural Health Services	1	2005	379	0.050	Why?
Value of Life	1	2001	98	0.050	Why?
Television	1	2004	411	0.050	Why?
Heterosexuality	1	2003	275	0.050	Why?
Automobiles	1	2001	117	0.050	Why?
Netherlands	1	2005	2086	0.050	Why?
Condoms	1	2003	325	0.050	Why?
Pacemaker, Artificial	1	2006	768	0.050	Why?
Vancomycin	2	2001	503	0.050	Why?
State Health Plans	1	2002	217	0.050	Why?
Women, Working	1	2001	84	0.050	Why?
Delivery, Obstetric	1	2007	903	0.050	Why?
DNA, Bacterial	1	2005	1526	0.050	Why?
Survivors	1	2010	2171	0.050	Why?
Insurance, Pharmaceutical Services	1	2002	343	0.050	Why?
Cardiovascular Agents	1	2006	867	0.040	Why?
Epidemiologic Studies	1	2002	637	0.040	Why?
Viral Load	2	2010	3242	0.040	Why?
Policy Making	1	2002	538	0.040	Why?
Homosexuality	1	1999	270	0.040	Why?
Salaries and Fringe Benefits	1	2001	271	0.040	Why?
Debridement	1	2001	500	0.040	Why?
Educational Status	2	2003	2340	0.040	Why?
AIDS Vaccines	1	2004	916	0.040	Why?
Survival Analysis	3	2007	10542	0.040	Why?
Public Health Practice	1	2000	212	0.040	Why?
Mammography	1	2008	2475	0.040	Why?
Logistic Models	2	2011	13605	0.040	Why?
Peritoneal Dialysis, Continuous Ambulatory	1	1996	29	0.040	Why?
Drug Administration Schedule	2	2002	5038	0.040	Why?
Infertility, Female	1	2003	763	0.040	Why?
Medical Oncology	1	2009	2124	0.040	Why?
Cytomegalovirus	2	2001	692	0.040	Why?
Appointments and Schedules	1	2001	432	0.040	Why?
Posture	1	2001	993	0.040	Why?
Carcinoma, Hepatocellular	1	2008	2089	0.040	Why?
Defibrillators, Implantable	1	2006	1407	0.040	Why?
Safety	1	2001	1220	0.040	Why?
Frail Elderly	1	2001	609	0.040	Why?
African Americans	1	2011	5025	0.040	Why?
Antibiotic Prophylaxis	1	2001	631	0.040	Why?
Accidents, Traffic	1	2001	805	0.040	Why?
Neoplasm Staging	3	2007	11200	0.040	Why?
Biopsy	1	2008	6753	0.040	Why?
Air Pollution, Indoor	1	2003	893	0.040	Why?
Diagnostic Errors	1	2003	1274	0.040	Why?
Medically Uninsured	1	2001	865	0.030	Why?
Morbidity	1	2001	1706	0.030	Why?
Child Behavior	1	2001	829	0.030	Why?
Enzyme-Linked Immunosorbent Assay	1	2003	3968	0.030	Why?
Urban Population	1	2003	2025	0.030	Why?
Information Dissemination	1	2004	1100	0.030	Why?
Sex Factors	1	2009	10661	0.030	Why?
Preventive Health Services	1	2000	585	0.030	Why?
Liver Diseases	1	2003	1255	0.030	Why?
Health Care Surveys	1	2002	2511	0.030	Why?
Polymerase Chain Reaction	2	2001	6294	0.030	Why?
Blotting, Western	1	2003	5438	0.030	Why?
Rural Population	1	2005	2168	0.030	Why?
Peritonitis	1	1996	377	0.030	Why?
Attitude to Health	1	2004	2102	0.030	Why?
Medicaid	2	2005	2636	0.030	Why?
Gynecology	1	1999	475	0.030	Why?
Reproducibility of Results	3	2008	19537	0.030	Why?
Software	1	2008	4367	0.030	Why?
Information Systems	1	1976	390	0.030	Why?
Randomized Controlled Trials as Topic	3	2010	9578	0.030	Why?
Liver Cirrhosis	1	2003	1751	0.030	Why?
Body Composition	1	2002	2399	0.030	Why?
Cell Transformation, Neoplastic	1	2003	3016	0.030	Why?
Genomics	1	2009	5338	0.030	Why?
Databases, Factual	1	2008	7847	0.030	Why?
Obstetrics	1	1999	632	0.030	Why?
Peptide Fragments	1	2005	5160	0.030	Why?
Surgical Wound Infection	1	2001	1503	0.030	Why?
Colorectal Neoplasms	1	2011	6590	0.030	Why?
Coronary Artery Bypass	1	2001	2398	0.030	Why?
Adipose Tissue	1	2002	3243	0.020	Why?
Alkynes	1	2011	312	0.020	Why?
Seat Belts	2	2001	64	0.020	Why?
Cyclopropanes	1	2011	418	0.020	Why?
Population	1	2009	152	0.020	Why?
Health Knowledge, Attitudes, Practice	1	2004	3959	0.020	Why?
Spain	1	2010	468	0.020	Why?
Recurrence	1	2001	8284	0.020	Why?
Cytological Techniques	1	2010	219	0.020	Why?
Predictive Value of Tests	2	2001	15271	0.020	Why?
Follow-Up Studies	2	2007	39302	0.020	Why?
Survival Rate	1	2002	13262	0.020	Why?
Patient Acceptance of Health Care	1	2002	2938	0.020	Why?
American Cancer Society	1	2007	62	0.020	Why?
Cross Infection	1	1996	1410	0.020	Why?
Liver Neoplasms	1	2002	4102	0.020	Why?
Toxoplasmosis, Cerebral	1	2006	19	0.020	Why?
International Cooperation	1	2013	1420	0.020	Why?
Drug Resistance, Microbial	2	2001	875	0.020	Why?
Mycobacterium Infections	1	2006	123	0.020	Why?
Isoproterenol	1	2006	414	0.020	Why?
Wounds and Injuries	1	1998	2416	0.020	Why?
Anti-Bacterial Agents	2	2001	7074	0.020	Why?
Georgia	1	2005	195	0.020	Why?
Severity of Illness Index	1	2003	16020	0.020	Why?
HIV Protease Inhibitors	1	2007	429	0.020	Why?
Social Justice	1	2009	421	0.020	Why?
Probability	1	2010	2489	0.020	Why?
Asthma	1	2003	5941	0.020	Why?
Adrenergic beta-Agonists	1	2006	360	0.020	Why?
Regression Analysis	2	2006	6480	0.020	Why?
Psychiatry	1	1976	1618	0.020	Why?
Reverse Transcriptase Inhibitors	1	2007	600	0.020	Why?
Blood Donors	1	2006	355	0.020	Why?
Hospitalization	2	2001	9754	0.020	Why?
Tachycardia	1	2006	609	0.010	Why?
Electrophysiologic Techniques, Cardiac	1	2006	470	0.010	Why?
Prognosis	1	2004	29226	0.010	Why?
Mycoses	1	2006	367	0.010	Why?
Haiti	1	2005	543	0.010	Why?
Retrospective Studies	4	2006	72608	0.010	Why?
Occupations	1	2005	511	0.010	Why?
World Health Organization	1	2008	1287	0.010	Why?
Pediatric Assistants	1	2001	8	0.010	Why?
Gestational Age	1	2010	3427	0.010	Why?
Algorithms	2	2002	13716	0.010	Why?
Radiotherapy, Adjuvant	1	2007	1841	0.010	Why?
Cardiac Pacing, Artificial	1	2006	846	0.010	Why?
Continuity of Patient Care	1	2009	1048	0.010	Why?
Natural Childbirth	1	2000	17	0.010	Why?
Multivariate Analysis	2	2006	12484	0.010	Why?
Anti-Arrhythmia Agents	1	2006	766	0.010	Why?
Infant, Premature	1	2010	2015	0.010	Why?
Cefazolin	1	2001	97	0.010	Why?
Disability Evaluation	1	2009	1826	0.010	Why?
Multicenter Studies as Topic	1	2006	1531	0.010	Why?
Vancomycin Resistance	1	2001	130	0.010	Why?
Methicillin Resistance	1	2001	202	0.010	Why?
Sexual Partners	1	2005	692	0.010	Why?
Sex Distribution	1	2006	2369	0.010	Why?
Uterine Cervical Diseases	1	2000	79	0.010	Why?
Cephalosporins